Our Promise

CardiaPill® is our lead product.

Chief Medical Officer

Frank A. Snyder, M.S., M.D.
Dr. Snyder is one of the originators of the CardiaPill concept. He holds an advanced degree in molecular biology and is a Medical Doctor. He is an Associate Professor of Medicine at the University of North Carolina at Chapel Hill and an Adjunct Professor in the Vascular Biology Working Group.

Dr. Snyder is the current Founder/Owner of Wilmington Internal Medicine. He was the former Director of the Pender Memorial Hospital Emergency Room and was former Chief of Medicine at Cape Fear Memorial Hospital. Dr. Snyder is a well-respected personality in the biotech/pharmaceutical industry and has served as a lecturer/consultant for many big pharmaceutical companies including Pfizer, Kos, Glaxo Welcome, Sankyo, Wyeth, Monarch, Novartis, Liposcience, Tanabe and AAI Pharma, as well as several biotechnology investment groups.